| A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction CW Tan, WN Chia, X Qin, P Liu, MIC Chen, C Tiu, Z Hu, VCW Chen, ... Nature biotechnology 38 (9), 1073-1078, 2020 | 1377 | 2020 |
| Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients AT Tan, M Linster, CW Tan, N Le Bert, WN Chia, K Kunasegaran, ... Cell reports 34 (6), 2021 | 851 | 2021 |
| Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia S Wacharapluesadee, CW Tan, P Maneeorn, P Duengkae, F Zhu, ... Nature communications 12 (1), 972, 2021 | 483 | 2021 |
| Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study PY Chia, SWX Ong, CJ Chiew, LW Ang, JM Chavatte, TM Mak, L Cui, ... Clinical microbiology and infection 28 (4), 612. e1-612. e7, 2022 | 432 | 2022 |
| Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study WN Chia, F Zhu, SWX Ong, BE Young, SW Fong, N Le Bert, CW Tan, ... The Lancet Microbe 2 (6), e240-e249, 2021 | 422 | 2021 |
| Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host M Ahn, DE Anderson, Q Zhang, CW Tan, BL Lim, K Luko, M Wen, ... Nature microbiology 4 (5), 789-799, 2019 | 364 | 2019 |
| Connecting clusters of COVID-19: an epidemiological and serological investigation SEF Yong, DE Anderson, WE Wei, J Pang, WN Chia, CW Tan, YL Teoh, ... The Lancet infectious diseases 20 (7), 809-815, 2020 | 308 | 2020 |
| Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor CW Tan, CL Poh, IC Sam, YF Chan Journal of virology 87 (1), 611-620, 2013 | 232 | 2013 |
| Pan-sarbecovirus neutralizing antibodies in BNT162b2-immunized SARS-CoV-1 survivors CW Tan, WN Chia, BE Young, F Zhu, BL Lim, WR Sia, TL Thein, ... New England Journal of Medicine 385 (15), 1401-1406, 2021 | 227 | 2021 |
| Discovery and genomic characterization of a 382-nucleotide deletion in ORF7b and ORF8 during the early evolution of SARS-CoV-2 YCF Su, DE Anderson, BE Young, M Linster, F Zhu, J Jayakumar, ... MBio 11 (4), 10.1128/mbio. 01610-20, 2020 | 216 | 2020 |
| Viral dynamics and immune correlates of coronavirus disease 2019 (COVID-19) severity BE Young, SWX Ong, LFP Ng, DE Anderson, WN Chia, PY Chia, LW Ang, ... Clinical Infectious Diseases 73 (9), e2932-e2942, 2021 | 215 | 2021 |
| Characterization of a filovirus (Měnglà virus) from Rousettus bats in China XL Yang, CW Tan, DE Anderson, RD Jiang, B Li, W Zhang, Y Zhu, XF Lim, ... Nature microbiology 4 (3), 390-395, 2019 | 211 | 2019 |
| A zoonotic henipavirus in febrile patients in China XA Zhang, H Li, FC Jiang, F Zhu, YF Zhang, JJ Chen, CW Tan, ... New England Journal of Medicine 387 (5), 470-472, 2022 | 208 | 2022 |
| Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles AM Gamage, KS Tan, WOY Chan, J Liu, CW Tan, YK Ong, M Thong, ... PLoS pathogens 16 (12), e1009130, 2020 | 125 | 2020 |
| Serological differentiation between COVID-19 and SARS infections WN Chia, CW Tan, R Foo, AEZ Kang, Y Peng, V Sivalingam, C Tiu, ... Emerging microbes & infections 9 (1), 1497-1505, 2020 | 111 | 2020 |
| Polysulfonate suramin inhibits Zika virus infection CW Tan, IC Sam, WL Chong, VS Lee, YF Chan Antiviral research 143, 186-194, 2017 | 108 | 2017 |
| Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2 DE Anderson, CW Tan, WN Chia, BE Young, M Linster, JGH Low, YJ Tan, ... Emerging microbes & infections 9 (1), 900-902, 2020 | 107 | 2020 |
| Recent developments in antiviral agents against enterovirus 71 infection CW Tan, JKF Lai, IC Sam, YF Chan Journal of biomedical science 21 (1), 14, 2014 | 90 | 2014 |
| WHO international standard for SARS-CoV-2 antibodies to determine markers of protection F Zhu, T Althaus, CW Tan, A Costantini, WN Chia, NVV Chau, L Van Tan, ... The Lancet Microbe 3 (2), e81-e82, 2022 | 79 | 2022 |
| SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness C Jeewandara, D Jayathilaka, L Gomes, A Wijewickrama, E Narangoda, ... Scientific reports 11 (1), 2062, 2021 | 68 | 2021 |
Linfa WangEID Programme, Duke-NUS Medical SchoolVerified email at duke-nus.edu.sg
